Technical Integration Blueprint

Huntress MDR with Bitdefender GravityZone NGAV Co-Existence Specs

Zero-conflict co-existence architecture pairing Bitdefender kernel-level protection with Huntress 24/7 human-backed MDR threat hunting.

How Huntress and Bitdefender Work Together

Bitdefender serves as the primary Next-Gen Antivirus (NGAV) blocking known malicious payloads and exploits on execution. Huntress runs alongside Bitdefender, scanning for living-off-the-land binaries, persistent footholds in registry autoruns, and compromised credentials.

Automated Data Flow Pipeline

Huntress ➔ Bitdefender Data Sync

Real-time webhook protocol mapping showing trigger events, payloads, and automated target actions.

Step Origin / Trigger Event & Handshake Target Destination Action Taken
01 Endpoint Activity Event Kernel-level filter driver audit Bitdefender Real-Time Shield Automated record sync
02 Huntress Persistence Monitor Scheduled registry & scheduled-task inspection Huntress 24/7 Human SOC Portal Automated record sync
Supported Protocols: Huntress Windows/macOS Agent Bitdefender GravityZone Endpoint SDK Syslog / SIEM Event Stream Latency: real time webhook
Total Cost of Ownership (TCO) Baseline

Huntress + Bitdefender Stack: 3-Year Benchmark (25 Seats)

Comparing legacy monolithic enterprise suites against a connected modular stack with native automation.

Architecture Strategy Base License (Annual) Add-ons & API Overages Year 1 Total Year 3 Total Cost Variance
Legacy All-In-One Enterprise Suite $80,000 $14,400 $94,400 $283,200 Baseline
Connected Modular Stack (Native Sync) $36,250 $0 (Native Webhooks) $36,250 $108,750 Save ~62% ($174,450)

*Data based on verified enterprise rate cards and standard API quota tiers. Modular setups eliminate third-party middleware subscriptions and custom ETL maintenance costs.

Integration FAQ & Gotchas

Will running Huntress and Bitdefender cause endpoint slowdowns?

No. When configured with mutual process exclusions, the combined RAM footprint is under 350MB and CPU utilization remains below 2% during normal operations.